Yi Shi

Yi Shi, Ph.D. has served as Director of Ansun since April 2018. He is the Founder and Managing Partner of Lilly Asia Ventures, a biomedical venture capital firm with a focus on China and cross-border opportunities. Prior to his current role, Yi worked at Eli Lilly and Company in business development licensing and corporate ventures. His education includes a Ph.D. in Biochemistry and a Master of Business Administration, both from Duke University. He also has a Bachelor of Sciences in Biology from the University of Science and Technology of China.